Synjardy XR 1000 mg/1

Synjardy XR 1000 mg/1 combines empagliflozin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes.

Synjardy XR 1000 mg/1 is designed to help manage blood sugar levels in adults with type 2 diabetes. It works by combining two active ingredients, empagliflozin and metformin hydrochloride, to improve glycemic control. This medication is typically used as part of a broader treatment plan that includes diet and exercise. People often ask, 'What is Synjardy XR used for?' and the primary purpose is to assist in maintaining stable blood sugar levels.

Common effects of Synjardy XR 1000 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience urinary tract infections or low blood sugar, especially when combined with other diabetes medications. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Synjardy XR 1000 mg/1 should be handled with care, especially for those with kidney issues or a history of metabolic acidosis. It is crucial to follow the prescribed dosage and administration instructions. The extended-release tablets should be swallowed whole and not crushed or chewed. Always store the medication as directed and keep it out of reach of children.

Synjardy XR 1000 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of low blood sugar and other adverse effects. It's important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.